The JAK2/STAT3 signaling pathway is required for growth of CD44(+) CD24(−) stem cell-like breast cancer cells, particularly in basal-like breast cancers and is independently associated with breast cancer metastasis and poor prognosis32,33. Here, JAK2 is linked to breast carcinoma.